Paper20097142
Cholangiocarcinoma: update and future perspectives.
Gatto M and 7 others. Dig Liver Dis, 2010. Cited by 148 papers, by iCite.
Cite this record
ConductScience Library. Cholangiocarcinoma: update and future perspectives. Papers, record 20097142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20097142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Duct Neoplasms | Major topic |
| Bile Ducts, Intrahepatic | Major topic |
| Cholangiocarcinoma | Major topic |
| Biomarkers | |
| Humans | |
| Risk Factors |
Source PubMed
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 148 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42129907 | Assessing the impact of Fasciola hepatica excretory-secretory antigens on A549 cells: viability, apoptosis, ROS, and stem cell markers. | BMC Res Notes | 2026 | https://conductscience.org/library/papers/42129907 | PubMed |
| 40859233 | Cholecystitis and cholangiocarcinoma: a two-sample Mendelian randomization study. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40859233 | PubMed |
| 38779292 | A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy. | Cureus | 2024 | https://conductscience.org/library/papers/38779292 | PubMed |
| 38761410 | The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand. | Int J Cancer | 2024 | https://conductscience.org/library/papers/38761410 | PubMed |
| 38577184 | National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38577184 | PubMed |
| 37868248 | A Call To Action: Cholangiocarcinoma in the Setting of Sustained Hepatitis C Virologic Response - Case Report and Review of Literature. | J Community Hosp Intern Med Perspect | 2023 | https://conductscience.org/library/papers/37868248 | PubMed |
| 37368186 | Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes. | Hepatol Int | 2023 | https://conductscience.org/library/papers/37368186 | PubMed |
| 36505756 | Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer. | Mediators Inflamm | 2022 | https://conductscience.org/library/papers/36505756 | PubMed |
| 35225471 | Effect of Betulinic acid Extraction from Guava (Psidium guajava Linn.) Leaves Against Human Cholangiocarcinoma Cells. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/35225471 | PubMed |
| 34829291 | Klatskin-Mimicking Lesions. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34829291 | PubMed |
| 34721719 | 68Ga-FAPI-46 PET/MR Detects Recurrent Cholangiocarcinoma and Intraductal Papillary Mucinous Neoplasm in a Patient Showing Increasing CEA with Negative 18F-FDG PET/CT and Conventional CT. | Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/34721719 | PubMed |
| 34440841 | Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. | Cells | 2021 | https://conductscience.org/library/papers/34440841 | PubMed |
| 33206846 | Photodynamic therapy of extrahepatic cholangiocarcinoma using digital cholangioscopy. | Arq Bras Cir Dig | 2020 | https://conductscience.org/library/papers/33206846 | PubMed |
| 33198229 | Severe Salmonella spp. or Campylobacter spp. Infection and the Risk of Biliary Tract Cancer: A Population-Based Study. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33198229 | PubMed |
| 31902744 | LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/31902744 | PubMed |
| 31616187 | Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31616187 | PubMed |
| 31571907 | Up-regulated LncRNA-ATB regulates the growth and metastasis of cholangiocarcinoma via miR-200c signals. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31571907 | PubMed |
| 31366338 | Favorable gallbladder cancer mortality-to-incidence ratios of countries with good ranking of world's health system and high expenditures on health. | BMC Public Health | 2019 | https://conductscience.org/library/papers/31366338 | PubMed |
| 30975121 | Is exposure to tobacco associated with extrahepatic cholangiocarcinoma epidemics? A retrospective proportional mortality study in China. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30975121 | PubMed |
| 30832707 | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. | Clin Epigenetics | 2019 | https://conductscience.org/library/papers/30832707 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20097142
GET https://conductscience.org/api/papers/v1/20097142/cited_by?page=2